ATP5PO and Alzheimer disease: Notably, the expression levels of the other major F1FO-ATP synthase subunits, including a, b, c, α, and β were not significantly changed in either MCI or AD brains (Supplementary Fig. 1a,b), implying that the OSCP loss is not likely a result of F1FO-ATP synthase reduction in AD.